Cargando…
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115378/ https://www.ncbi.nlm.nih.gov/pubmed/35602493 http://dx.doi.org/10.3389/fmed.2022.923790 |
| _version_ | 1784709924724408320 |
|---|---|
| author | Favalli, Ennio Giulio Gobbini, Andrea Bombaci, Mauro Maioli, Gabriella Biggioggero, Martina Pesce, Elisa Favalli, Andrea Martinovic, Martina Fabbris, Tanya Marchisio, Edoardo Bandera, Alessandra Gori, Andrea Abrignani, Sergio Grifantini, Renata Caporali, Roberto |
| author_facet | Favalli, Ennio Giulio Gobbini, Andrea Bombaci, Mauro Maioli, Gabriella Biggioggero, Martina Pesce, Elisa Favalli, Andrea Martinovic, Martina Fabbris, Tanya Marchisio, Edoardo Bandera, Alessandra Gori, Andrea Abrignani, Sergio Grifantini, Renata Caporali, Roberto |
| author_sort | Favalli, Ennio Giulio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9115378 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91153782022-05-19 Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study Favalli, Ennio Giulio Gobbini, Andrea Bombaci, Mauro Maioli, Gabriella Biggioggero, Martina Pesce, Elisa Favalli, Andrea Martinovic, Martina Fabbris, Tanya Marchisio, Edoardo Bandera, Alessandra Gori, Andrea Abrignani, Sergio Grifantini, Renata Caporali, Roberto Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-05-04 /pmc/articles/PMC9115378/ /pubmed/35602493 http://dx.doi.org/10.3389/fmed.2022.923790 Text en Copyright © 2022 Favalli, Gobbini, Bombaci, Maioli, Biggioggero, Pesce, Favalli, Martinovic, Fabbris, Marchisio, Bandera, Gori, Abrignani, Grifantini and Caporali. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Favalli, Ennio Giulio Gobbini, Andrea Bombaci, Mauro Maioli, Gabriella Biggioggero, Martina Pesce, Elisa Favalli, Andrea Martinovic, Martina Fabbris, Tanya Marchisio, Edoardo Bandera, Alessandra Gori, Andrea Abrignani, Sergio Grifantini, Renata Caporali, Roberto Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title | Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title_full | Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title_fullStr | Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title_full_unstemmed | Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title_short | Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study |
| title_sort | corrigendum: the impact of anti-rheumatic drugs on the seroprevalence of anti-sars-cov-2 antibodies in a cohort of patients with inflammatory arthritis: the mainstream study |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115378/ https://www.ncbi.nlm.nih.gov/pubmed/35602493 http://dx.doi.org/10.3389/fmed.2022.923790 |
| work_keys_str_mv | AT favallienniogiulio corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT gobbiniandrea corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT bombacimauro corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT maioligabriella corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT biggioggeromartina corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT pesceelisa corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT favalliandrea corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT martinovicmartina corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT fabbristanya corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT marchisioedoardo corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT banderaalessandra corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT goriandrea corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT abrignanisergio corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT grifantinirenata corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy AT caporaliroberto corrigendumtheimpactofantirheumaticdrugsontheseroprevalenceofantisarscov2antibodiesinacohortofpatientswithinflammatoryarthritisthemainstreamstudy |